1.06574

リン酸ナトリウム 二塩基性 七水和物

EMPROVE^® ESSENTIAL, DAC, USP

• 別名: リン酸二ナトリウム, リン酸水素二ナトリウム 七水和物
• 化学式: Na₂HPO₄ · 7H₂O
• CAS番号: 7782-85-6
• 分子量: 268.07
• MDL番号: MFCD00149180
• UNSPSCコード: 12352302
• EC Index Number: 231-448-7

特性

• 認証: DAC; USP
• 品質水準: 500
• 蒸気密度: 4.9 (vs air)
• 製品種目: EMPROVE^® ESSENTIAL
• 形状: solid
• pH: 8.7-9.3 (25 °C, 50 g/L in H₂O)
• mp: 48 °C (Elimination of water of crystallisation)
• 溶解性: 154 g/L
• 密度: 1.68 g/mL at 25 °C (lit.)
• アプリケーション: liquid formulation; ophthalmics; pharmaceutical; semi-solid formulation; solid formulation
• 保管温度: 2-30°C
• SMILES記法: O.O.O.O.O.O.O.[Na+].[Na+].OP([O-])([O-])=O
• InChI: 1S/2Na.H3O4P.7H2O/c;;1-5(2,3)4;;;;;;;/h;;(H3,1,2,3,4);7*1H2/q2*+1;;;;;;;;/p-2
• InChI Key: PYLIXCKOHOHGKQ-UHFFFAOYSA-L

詳細

詳細

Finding the right excipient that matches your needs as well as regulatory demands can be a complicated challenge. With our application know-how and regulatory expertise, we support you in every step of development, scale-up, and production.
As part of our Emprove^® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC^® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

アプリケーション

di-Sodium hydrogen phosphate heptahydrate is typically used as a phosphate buffer system component for biomolecule downstream chromatography steps or final liquid formulation.

法的情報

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany

SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

安全性情報

• 保管分類コード: 13 - Non Combustible Solids
• WGK: WGK 1
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable